Growing Demand From End-Use Industries

The vials are essentially used within autosamplers so as to attach tightly to the specific dimensions while performing the analytical tests in laboratories’ testing programs such as impurity investigation, stability tests, quantity verification and many more. With the advent of technological advancements and enhancements in autosamplers, the demand for autosampler vials from different end-use industries such as food industry, pharmaceutical industry, oil and gas industry, etc. has increased, thereby enabling the growth of the market. Moreover, increased adoption of high-performance liquid chromatography (HPLC) and gas chromatography (GC) tests for sample purification, food and drug quality control etc. are contributing to the rise in demand for labware and consumables associated with the process.

Technological Innovations

Various product innovations are expected to positively impact the growth of autosampler market. Highly inert products made up of clear glass and amber glass are vastly preferred products, out of which, Amber glass helps in avoiding exposure to UV light thus protecting the samples of sensitive nature. 

Moreover, autosampler vials are time efficient when compared to the manual injection method. Once the samples are prepared and the analysis sequence is set, the technician is free to attend other tasks.

Restraints

Factors such as spending priorities and available resources along with product and economic cycles, have a significant effect on the spending policies of the hospitals, research laboratories, pharmaceutical companies, contract research organizations, etc. Depending upon the budget allocations and the timely passage of the annual federal budget, the investments allocated for various research projects could fluctuate, which further impacts the utilization of consumable products such as autosampler vials.

Region-Wise Growth Highlights – 2020-2027

The global autosampler vials market is segmented into five major regions comprising of North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

North America held the highest market share of 34.13% in 2018 as compared to the other regions and is estimated to reach a market size of USD 513.23 million by end of forecast period. Improved laboratory infrastructure and increased funds for R&D in healthcare industry along with the growing initiatives taken by the U.S. government to upgrade the infrastructure in pharmaceutical industry, are the primary driving factors for the market growth in this region. According to OECD, in 2017, total pharmaceutical spending in the U.S. reached 1220.4 USD per capita, which covered expenditure on prescription medicines and self-medication.

The second highest growth is estimated to be witnessed by the market in Europe that is anticipated to hold around 30% share in the autosampler vials market. Europe autosampler vials market is significantly growing on account of the increasing government support in major countries of Europe such as Germany, UK, Spain, Russia. In addition, the increasing R&D expenditure (as % of GDP) of major countries of Europe is also contributing to the growth of autosampler vials market.

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).